State of Michigan Retirement System’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-200,000
Closed -$28.5M 957
2024
Q2
$28.5M Hold
200,000
0.15% 117
2024
Q1
$25.7M Buy
+200,000
New +$23.8M 0.14% 127
2016
Q4
Sell
-76,400
Closed -$1.59M 969
2016
Q3
$1.59M Hold
76,400
0.01% 687
2016
Q2
$2.05M Sell
76,400
-76,600
-50% -$2.1M 0.02% 596
2016
Q1
$4.15M Hold
153,000
0.03% 377
2015
Q4
$4.44M Hold
153,000
0.03% 347
2015
Q3
$4.15M Hold
153,000
0.03% 382
2015
Q2
$4.19M Hold
153,000
0.03% 418
2015
Q1
$4.08M Hold
153,000
0.03% 443
2014
Q4
$3.24M Hold
153,000
0.02% 520
2014
Q3
$3.64M Hold
153,000
0.03% 467
2014
Q2
$3.53M Hold
153,000
0.02% 489
2014
Q1
$3.49M Hold
153,000
0.03% 469
2013
Q4
$2.83M Hold
153,000
0.02% 530
2013
Q3
$2.59M Hold
153,000
0.02% 536
2013
Q2
$2.37M Buy
+153,000
New +$2.55M 0.02% 529

Other funds holding NVO

State of Michigan Retirement System's NVO Position: Q3 2024 in Review

State of Michigan Retirement System sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 200,000 shares — an estimated $28.5M sold.

State of Michigan Retirement System first reported a position in NVO in Q2 2013 and held it in 16 quarters. The position peaked at $28.5M in Q2 2024. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • State of Michigan Retirement System reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • State of Michigan Retirement System sold 200,000 Novo Nordisk shares in Q3 2024, an estimated $28.5M.
  • State of Michigan Retirement System first reported a position in Novo Nordisk in Q2 2013 and held it in 16 quarters.
  • State of Michigan Retirement System's Novo Nordisk position peaked at $28.5M in Q2 2024.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on State of Michigan Retirement System's 13F filing for Q3 2024, filed 4 Nov 2024.